WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Transplant Product Efficacy Framework v11a - Deletion Candidates, Banff grade is staged as IIB, defined time points including 12 months, Estimated GFR (eGFR) accounts for Serum Creatinine (SCr), Transplant Recipient has accumulated Medical History (Recipient), Transplant Donor has accumulated Medical History (Donor), Medical History (Recipient) contains Urine Output, Banff grade is staged as IIA, Medical History (Recipient) contains Dialysis Prior to Transplant, Diagnosis includes Diabetes, Approved Concomitant Anti-rejection therapy has (1..n) Drug Name, EBV increases risk for PTLD (post-transplant lymphoproliferative disorder), Study Drug | Comparator has value for Dosage, Study Drug | Comparator taken in combination with Induction Agent, Glomerular Filtration Rate (GFR) is associated with Cardiovascular (CV) risk, Diagnosis includes Hypertension, CV death can result from Toxicity, Estimated GFR (eGFR) is correlated with Graft Loss, Transplant Donor has HLA types, Transplant Donor has donor type Living-non-related, Medical History (Recipient) contains BMI